IBDEI052 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6492,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,6492,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,6493,0)
 ;;=224.0^^37^403^11
 ;;^UTILITY(U,$J,358.3,6493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6493,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,6493,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,6493,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,6494,0)
 ;;=364.72^^37^403^6
 ;;^UTILITY(U,$J,358.3,6494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6494,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,6494,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,6494,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,6495,0)
 ;;=364.71^^37^403^102
 ;;^UTILITY(U,$J,358.3,6495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6495,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,6495,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,6495,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,6496,0)
 ;;=364.00^^37^403^57
 ;;^UTILITY(U,$J,358.3,6496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6496,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,6496,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,6496,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,6497,0)
 ;;=379.40^^37^403^106
 ;;^UTILITY(U,$J,358.3,6497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6497,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,6497,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,6497,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,6498,0)
 ;;=190.0^^37^403^84
 ;;^UTILITY(U,$J,358.3,6498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6498,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,6498,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,6498,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,6499,0)
 ;;=190.3^^37^403^83
 ;;^UTILITY(U,$J,358.3,6499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6499,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,6499,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,6499,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,6500,0)
 ;;=364.41^^37^403^50
 ;;^UTILITY(U,$J,358.3,6500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6500,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,6500,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,6500,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,6501,0)
 ;;=364.05^^37^403^51
 ;;^UTILITY(U,$J,358.3,6501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6501,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,6501,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,6501,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,6502,0)
 ;;=365.02^^37^403^4
 ;;^UTILITY(U,$J,358.3,6502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6502,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,6502,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,6502,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,6503,0)
 ;;=372.63^^37^403^117
 ;;^UTILITY(U,$J,358.3,6503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6503,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,6503,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,6503,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,6504,0)
 ;;=372.75^^37^403^27
 ;;^UTILITY(U,$J,358.3,6504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6504,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,6504,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,6504,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,6505,0)
 ;;=364.81^^37^403^43
 ;;^UTILITY(U,$J,358.3,6505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6505,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,6505,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,6505,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,6506,0)
 ;;=006.9^^37^403^2
 ;;^UTILITY(U,$J,358.3,6506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6506,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,6506,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,6506,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,6507,0)
 ;;=190.8^^37^403^60
 ;;^UTILITY(U,$J,358.3,6507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6507,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,6507,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,6507,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,6508,0)
 ;;=224.1^^37^403^93
 ;;^UTILITY(U,$J,358.3,6508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6508,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,6508,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,6508,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,6509,0)
 ;;=360.33^^37^403^52
 ;;^UTILITY(U,$J,358.3,6509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6509,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,6509,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,6509,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,6510,0)
 ;;=224.8^^37^403^86
 ;;^UTILITY(U,$J,358.3,6510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6510,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,6510,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,6510,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,6511,0)
 ;;=364.01^^37^403^103
 ;;^UTILITY(U,$J,358.3,6511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6511,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,6511,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,6511,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,6512,0)
 ;;=364.04^^37^403^53
 ;;^UTILITY(U,$J,358.3,6512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6512,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,6512,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,6512,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,6513,0)
 ;;=364.21^^37^403^46
 ;;^UTILITY(U,$J,358.3,6513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6513,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,6513,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,6513,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,6514,0)
 ;;=364.23^^37^403^81
 ;;^UTILITY(U,$J,358.3,6514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6514,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,6514,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,6514,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,6515,0)
 ;;=364.51^^37^403^8
 ;;^UTILITY(U,$J,358.3,6515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6515,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,6515,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,6515,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,6516,0)
 ;;=364.53^^37^403^100
 ;;^UTILITY(U,$J,358.3,6516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6516,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,6516,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,6516,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,6517,0)
 ;;=364.57^^37^403^33
 ;;^UTILITY(U,$J,358.3,6517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6517,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,6517,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,6517,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,6518,0)
 ;;=364.60^^37^403^26
 ;;^UTILITY(U,$J,358.3,6518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6518,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,6518,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,6518,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,6519,0)
 ;;=364.73^^37^403^97
 ;;^UTILITY(U,$J,358.3,6519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6519,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,6519,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,6519,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,6520,0)
 ;;=364.75^^37^403^107
 ;;^UTILITY(U,$J,358.3,6520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6520,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,6520,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,6520,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,6521,0)
 ;;=364.76^^37^403^58
 ;;^UTILITY(U,$J,358.3,6521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6521,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,6521,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,6521,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,6522,0)
 ;;=364.77^^37^403^3
 ;;^UTILITY(U,$J,358.3,6522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6522,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,6522,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,6522,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,6523,0)
 ;;=364.89^^37^403^62
 ;;^UTILITY(U,$J,358.3,6523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6523,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,6523,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,6523,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,6524,0)
 ;;=364.9^^37^403^61
 ;;^UTILITY(U,$J,358.3,6524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6524,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,6524,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,6524,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,6525,0)
 ;;=370.00^^37^403^25
 ;;^UTILITY(U,$J,358.3,6525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6525,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,6525,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,6525,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,6526,0)
 ;;=370.20^^37^403^66
 ;;^UTILITY(U,$J,358.3,6526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6526,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
 ;;^UTILITY(U,$J,358.3,6526,1,4,0)
 ;;=4^370.20
 ;;^UTILITY(U,$J,358.3,6526,2)
 ;;=^268918
 ;;^UTILITY(U,$J,358.3,6527,0)
 ;;=370.31^^37^403^99
 ;;^UTILITY(U,$J,358.3,6527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6527,1,3,0)
 ;;=3^Phlyctenule Keratoconj
 ;;^UTILITY(U,$J,358.3,6527,1,4,0)
 ;;=4^370.31
 ;;^UTILITY(U,$J,358.3,6527,2)
 ;;=^268928^017.30
 ;;^UTILITY(U,$J,358.3,6528,0)
 ;;=370.8^^37^403^65
 ;;^UTILITY(U,$J,358.3,6528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6528,1,3,0)
 ;;=3^Keratitis,Oth Forms
 ;;^UTILITY(U,$J,358.3,6528,1,4,0)
 ;;=4^370.8
 ;;^UTILITY(U,$J,358.3,6528,2)
 ;;=^87595
 ;;^UTILITY(U,$J,358.3,6529,0)
 ;;=371.24^^37^403^23
 ;;^UTILITY(U,$J,358.3,6529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6529,1,3,0)
 ;;=3^Corneal Edema,Sec Contact Lens
 ;;^UTILITY(U,$J,358.3,6529,1,4,0)
 ;;=4^371.24
 ;;^UTILITY(U,$J,358.3,6529,2)
 ;;=^268969
